“Body Mass Index, Comorbidities, and the New Lancet Obesity Definition: Implications for Risk Analysis in Plastic and Reconstructive Surgery”
These findings partially support this new definition in the context of PRS. For patients with BMIs of 25-34.9 without comorbidities, weight loss may not change surgical risk. Comprehensive assessment of comorbidities should be considered for patients with BMIs 25-34.9, while weight loss or other risk mitigation strategies such as GLP-1 agonists may be recommended for patients with BMIs ≥35.
Authors
- Manuela Neira (ORCID: https://orcid.org/0009-0005-7369-3981)
- Micaela Tobin (ORCID: https://orcid.org/0000-0002-8905-3250)
- Ryan P. Cauley (ORCID: https://orcid.org/0000-0001-8291-433X)
- Bernard T. Lee (ORCID: https://orcid.org/0000-0002-5533-3166)
- Sarah J. Karinja (ORCID: https://orcid.org/0009-0005-6431-2892)
- Sophia Ahn
- Audrey Mustoe
- Tricia Mae Raquepo
- Anirudh Kulkarni
- Mohammed Yamin
Institutions
- Beth Israel Deaconess Medical Center (US)
Publication Details
- Journal
- Plastic & Reconstructive Surgery
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1097/prs.0000000000012830
- Primary Topic
- Body Contouring and Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00